Zdrowie i gospodarka · 09/05/2013

FDA to Host Public Hearing on Generic Drug User Fee Amendments and Regulatory Science Initiatives

The US Food and Drug Administration (FDA) is seeking public comments on proposed changes to the Generic Drug User Fee Amendments of 2012 and regulatory science initiatives, following a public hearing scheduled for later this year.